April 21, 2016
Nippon Boehringer Ingelheim’s triple combo hypertension drug failed to clear a key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on April 20 as some panel members questioned how meaningful it is to encapsulate three compounds in...read more